← USPTO Patent Grants

PDCD-1 homing endonuclease variants

Grant US12577547B2 Kind: B2 Mar 17, 2026

Assignee

REGENERON PHARMACEUTICALS, INC.

Inventors

Jordan Jarjour, Kyle Havens, Jasdeep Mann

Abstract

The present disclosure provides improved homing endonuclease variants and megaTALs reprogrammed to bind and cleave the PDCD-1 gene.

CPC Classifications

C12N 9/22 C12N 15/85 C12N 15/907 A61K 35/17

Filing Date

2019-12-09

Application No.

17311455

Claims

18